A carregar...

DHA-SBT-1214 Taxoid Nanoemulsion and Anti-PD-L1 Antibody Combination Therapy Enhances Anti-Tumor Efficacy in a Syngeneic Pancreatic Adenocarcinoma Model

The goal of this study was to evaluate combination of a novel taxoid, DHA-SBT-1214 chemotherapy in modulating immune checkpoint marker expression and ultimately in improving antibody-based checkpoint blockade therapy in pancreatic adenocarcinoma (PDAC). DHA-SBT-1214 was encapsulated in an oil-in-wat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Ther
Main Authors: Ahmad, Gulzar, Mackenzie, Gerardo G., Egan, James, Amiji, Mansoor M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825580/
https://ncbi.nlm.nih.gov/pubmed/31439714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-18-1046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!